Early bird registration is open and closes May 2025. Register now
  • 00Days
  • 00Hrs
  • 00Mins
  • 00Secs
Submit an Abstract
Register now
Search

Taisho Pharmaceuticals Co., Ltd

Taisho Pharmaceutical Holdings is a Japanese company that aims to contribute to healthier living for all while raising the enterprise value of the Group as a whole. The company supports health and wellbeing through a comprehensive range of over-the-counter (OTC) treatments and prescription pharmaceuticals

Share This Partner / Exhibitor

Key dates

  • Abstract Submissions Open
    21 August 2024
  • Abstract Submissions Close
    EXTENDED 28 March 2025
    CLOSED 18 April 2025
  • Early Bird Registrations
    EXTENDED February to 6 May 2025
    CLOSED 20 May 2025
  • Late Abstract Submissions Open
    30 May 2025
  • Late Abstract Submissions Close
    29 June 2025
  • Abstract Acceptance Notification
    June 2025
  • Standard Registrations
    7 May to 3 August 2025
  • Late Registrations
    4 August to September 2025
  • APLAR 2025 Congress
    3-7 September 2025

More Partners / Exhibitors

EMJ Rheum

EMJ

Novartis
Ono Pharma

Ono Pharmaceutical
Meeting Place Fukuoka

FCVB

Gilead Sciences

Taisho Pharmaceuticals Co., Ltd
About
Partnership / Exhibition
Program
Follow
Facebook Instagram Linkedin X-twitter

Stay updated with APLAR Congress, and other related events. 

From key date reminders, abstract closures, program release updates, and speaker announcements, the best place to stay across APLAR Congress information is with the official congress mailing list. 

Join mailing list

You can opt out at anytime. 

If you are translating this website, phrase based translation is used and may not be completely accurate.

Designed and built by MCI Australia